Latest Pioglitazone Stories
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
New JARDIANCE Simple Savings program currently offered in doctors' offices and online RIDGEFIELD, Conn. and INDIANAPOLIS, Aug.
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
Takeda Pharmaceuticals Co. and Eli Lilly & Co.
The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform
OSAKA, Japan and DURHAM, N.C., July 10, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc.
The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB)
In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington,
Pre-Settlement Case Funding Firm announces new program focus for plaintiffs who used Actos, as well as Byetta, Januvia, and Victoza NEW ORLEANS, June 19, 2014 /PRNewswire/ -- Legal-Bay
A jury in Louisiana has determined that Takeda Pharmaceuticals and Eli Lilly & Co.